Sandoz launches oncology generic gefitinib in 13 EU countries

This article was originally published here

The medicine will become available immediately in 13 countries across Europe on the day the reference medicine loses market exclusivity. Sandoz will continue to expand to other countries

The post Sandoz launches oncology generic gefitinib in 13 EU countries appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply